Antistaphylococcal Activity of Dalbavancin, an Experimental Glycopeptide

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.49.2.770-772.2005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vivo Pharmacodynamic Activity of the Glycopeptide Dalbavancin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2007English

Antistaphylococcal Activity of New Salicylamide Analogues

2019English

Antistaphylococcal Activities of Teicoplanin and Vancomycin in Vitro and in an Experimental Infection.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1990English

In Vitro Activity of LY333328, an Investigational Glycopeptide Antibiotic, Against Enterococci and Staphylococci.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1996English

Antistaphylococcal Activity of Ceftobiprole, a New Broad-Spectrum Cephalosporin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium Difficile

Frontiers in Microbiology
Microbiology
2018English

Antistaphylococcal Activity of Extracts, Fractions, and Compounds of Acacia Polyacantha Wild (Fabaceae)

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2020English

Antimicrobial Activity of MDL 63,246, a New Semisynthetic Glycopeptide Antibiotic

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1995English

In Vitro Activity of Decaplanin (M86-1410), a New Glycopeptide Antibiotic.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy